Figure 4 - available via license: CC BY-NC
Content may be subject to copyright.
Download
View publication
Apical Four-Chamber View Demonstrating Mural Left Ventricular Apical Thrombus in a Patient with Recent Anterior Transmural Myocardial Infarction.

Apical Four-Chamber View Demonstrating Mural Left Ventricular Apical Thrombus in a Patient with Recent Anterior Transmural Myocardial Infarction.

Source publication
Figure 1 Assessment of Right Ventricular Systolic Function by Tricuspid...
Figure 4 Apical Four-Chamber View Demonstrating Mural Left Ventricular...
Figure 6 Inflow Cannula Velocity Measured from an Off-axis Apical...
Figure 7 Tricuspid Regurgitation Doppler and Inferior Vena Cava M-mode...
+1 Echocardiographic Parameters Used in Grading the Severity of Tricuspid...
Continuous Flow Left Ventricular Assist Device Therapy: A Focused Review on Optimal Patient Selection and Long-Term Follow-up Using Echocardiography
Article
Full-text available
  • Oct 2015
Despite widespread awareness and use of scientifically proven life-prolonging medical and device-based therapies over the last two decades, heart failure remains a leading cause of morbidity, mortality, and health care expenditure in the United States. Mechanical circulatory support with a continuous-flow left ventricular assist device (CF-LVAD), e...
Cite
Download full-text

Context in source publication

Context 1
... images are of limited quality, echocardiography contrast agents should be used as they significantly improve the sensitivity, specificity, and accuracy of echocardiography in diagnosing LV thrombus [22]. An example is shown in Figure 4. ...

Similar publications

Figure 1. Cardiogenic Shock Algorithm developed by the INOVA Heart and...
Table 4 .
Cardiogenic Shock in the Setting of Acute Myocardial Infarction
Article
Full-text available
  • Jan 2020
Cardiogenic shock in the setting of acute myocardial infarction remains a major cause of morbidity and mortality. In fact, acute myocardial infarction accounts for 81% of patients in cardiogenic shock. Despite advances in pharmacologic and device-based approaches to support patients with cardiogenic shock, no significant improvement in mortality ha...
View
Weighted mean age reported for patients stratified by LVAD indication...
Incidence of adverse events (%)
Incidence of adverse events expressed as number of events per patient-year
Contemporary outcomes of continuous-flow left ventricular assist devices—a systematic review
Article
Full-text available
  • Mar 2021
Background: End stage heart failure is a major cause of morbidity and mortality, and its prevalence is expected to rise with the ageing population. For suitable patients, orthotopic heart transplantation remains the gold standard therapy, however, a paucity of donor organs has led to the development of left ventricular assist devices (LVAD). These...
View